Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curosurf versus placebo for ventilated infants with severe bronchiolitis-associated ARDS
2017-001768-39Phase 3Terminated
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
- Start
- Nov 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in bronchiolitis and acute respiratory distress syndrome (ARDS) comparing Curosurf with Placebo (2 arms). Primary endpoint: Ventilator-free days through day 14. Started Nov 2020; status: terminated.
02
Drugs
Poractant alfa
03
Conditions
bronchiolitisacute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on 2017-001768-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001768-39.